Receptor tyrosine kinases regulate α 1D-adrenoceptor signaling properties: Phosphorylation and desensitization

Abstract

Human α 1D-adrenoceptors (truncated at the amino terminus (Δ1–79) to increase their membrane expression) were stably expressed in Rat-1 fibroblasts (1–1.5 pmol/mg protein). The receptors were functional as evidenced by a robust increase in intracellular calcium in response to noradrenaline. Using this cell line, the possibility that activation of receptor tyrosine kinases could modulate this adrenoceptor subtype was studied. It was observed that cell preincubation with insulin, IGF-I, EGF or PDGF markedly reduced the intracellular calcium increase observed in response to noradrenaline. Inhibitors of PI3K and PKC essentially blocked insulin-, IGF-I- and EGF-induced desensitizations. Interestingly, PDGF-induced α 1D-adrenergic desensitization was only partially ameliorated by PI3K inhibitors and was not affected by those of PKC. Insulin, IGF-I, EGF and PDGF induced concentration-dependent increases in the phosphorylation state of α 1D-adrenoceptors; phosphorylation took place on serine residues. Inhibitors of PI3K and PKC markedly reduced the effects of insulin, IGF-I and EGF on this parameter. These inhibitors only marginally reduced PDGF-induced α 1D-adrenoceptors phosphorylation. The ability of IGF-I to induce α 1D-adrenergic desensitization and phosphorylation was confirmed in cells expressing non-truncated rat α 1D-adrenenoceptors. Our data indicate that the function and phosphorylation state of α 1D-adrenoceptors is modulated by activation of receptor tyrosine kinases. Insulin, IGF-I and EGF actions take place through the action of PI3K and PKC; additional pathway(s) seem to participate in PDGF-induced α 1D-adrenoceptor desensitization and phosphorylation.